Ampullary Cancer clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)
Sorry, in progress, not accepting new patients
This is a multi-center, open-label, randomized, phase 2/3 trial of the bispecific antibody CTX-009 plus paclitaxel versus paclitaxel in patients with previously treated, unresectable advanced or metastatic biliary tract cancers.
San Francisco, California and other locations
Last updated: